Moreover, the stratified analysis suggested the molecular subtype or tumor stage influenced the prognostic value of FoxP3+ Tregs in certain types of cancer, but the prognostic variability may not be attributable to different scoring strategies, follow-up duration, multivariate corrected or not. The gene discussed is FOXP3; the disease is neoplasm.